As
of September 30, 2024, the Company’s subsidiaries are detailed in the table as follows:
SCHEDULE
OF COMPANY AND SUBSIDIARIES
| Name |
|
Date
of
Incorporation or
Establishment |
|
Place
of
Incorporation or
Establishment |
|
Percentage
of
Ownership |
|
Principal
Activity |
| Subsidiary: |
|
|
|
|
|
|
|
|
| Maius
Pharmaceutical Limited |
|
August
13, 2018 |
|
British
Virgin Islands |
|
100% |
|
Investment
holding |
| Maius
Pharmaceutical (Hong Kong) Co., Ltd. |
|
August
29, 2018 |
|
Hong
Kong |
|
100% |
|
Investment
holding |
ShangHai
Maius Pharmaceutical Co., Ltd.
|
|
July
14, 2015 |
|
PRC |
|
100% |
|
Provide
R&D of drugs |
| Maius
Pharma Technology Limited |
|
March 26, 2024 |
|
British Virgin Islands |
|
100% |
|
Investment holding |
| Maius
Pharma Technology (HK) Co., Limited |
|
April 12, 2024 |
|
Hong Kong |
|
100% |
|
Investment holding |
| Maius
Pharmaceutical (MACAO) Co., Limited |
|
June 14, 2024 |
|
Macao |
|
100% |
|
Investment holding |
|